Beware of Intel Euphoria<br />By Rev Shark<br />RealMoney.com Contributor<br />4/14/2010 8:29 AM EDT<br /><br /> Celebrate what you want to see more of.<br /> -- Thomas J. Peters<br /><br />The Intel (INTC) earnings report last night came in nicely ahead of analyst expectations. The stock is off to a strong start this morning and is taking the broader market along with it. Sentiment is downright euphoric and this already extended market looks ready to become even more extended.<br /><br />But we have had this situation before and Intel has seldom proved to be a lasting positive catalyst, even when it does issue a superb earnings report. According to Sentimentrader.com, there have been six times since 1997 when Intel was at a new annual higher prior to earnings. If you bought the open the next day and held for three days, you lost money every time, with an average loss of 2.7%. Overall, if you had bought Intel after earnings even when it wasn't at a new high and held for three days, you had a loss 15 out of 22 times.<br /><br />The point here is obvious: Intel does not tend to follow through on good earnings news. We saw a good example of this in January following the fourth quarter. I recall writing about the euphoric mood and the feeling that it was going to be up, up and away, and it turned out to be a short-term top.<br /><br />Of course, this time may be different. Intel may indeed light a fire under this already hot market and keep this trend running steadily higher. The extended technical conditions of the indices, the very positive mood, the history of Intel's action following earnings and the pressure to take gains on some good news are the right conditions for the bears to finally see some topping action, but this market has confounded them for way too long already.<br /><br />The game plan here isn't to be wildly bearish, but to be a bit careful about being sucked in to the celebratory mood. I certainly don't want to fight the trend, but I want to watch very closely for signs of a reversal. Intel's history of poor performance is not unknown and there will be some who are inclined to sell into the strength. Should that selling take hold, we want to be ready to move quickly to do some repositioning.<br /><br />If nothing else, we should have more interesting action now rather than this slow drift upward. Try to stay open minded and don't be too quick to think that Intel is going to keep driving this market straight up. On the other hand, it is foolish to look for a sudden collapse in this market and you have to have great respect for the dip buyers, who are going to give us some major underlying support.<br />-----------------------------<br />Briefingust:<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: KLIC +17.3% (also target raised to $10 at Oppenheimer following positive pre-announcement), INTC +4.6%, JPM +3.1%, LLTC +2.9%, CSX +1.3%.<br /><br />Select financial related names showing strength boosted by JPM earnings: AIB +6.1% (upgraded to Buy from Neutral at Goldman), RF +3.1%, HBAN +3.0%, IRE +2.5%, C +2.4% (enters agreement to sell its fund of hedge funds, hedge fund seeding and hedge fund advisory businesses to SkyBridge Capital), WFC +2.3%, BCS +1.7%, MS +1.5%, LYG +1.5%, XLF +1.4%, GS +1.3% (initiated with a Buy at Nomura), BBT +1.1%, RBS +1.1%.<br /><br />Select mortgage insurer names showing continued strength: ABK +11.1%, FNM +5.9%, PMI +3.8%, MBI +2.4%, AIG +1.6%. <br /><br />Select metals/mining stocks trading higher: AU +2.1%, MT +1.9%, RTP +1.6%, BBL +1.6%, BHP +1.2%.<br /><br />Select semi/tech related names showing strength boosted by INTC/LLTC results: SMH +3.5%, NVDA +3.2%, AMD +2.9%, TXN +2.4%, NSM +2.3%, BRCM +2.1%, ATML +2.0%, ONNN +1.8%, SNDK +1.8%, MU +1.8%, ADI +1.7%, DELL +1.5%, HPQ +0.9%, AAPL +0.6%.<br /><br />Select oil/gas related names trading higher: RDS.A +1.6%, BP +1.5%, SLB +1.4%, TOT +1.3%.<br /><br />Other news: AEN +82.9% (announces positive results of Part 1 of CopperProof-2 study in Alzheimer's disease and mild congenitive impairment), BLTI +42.6% (light volume; announced that it was awarded a new patent for technology that is utilized in the groundbreaking ezlase and iLase diode lasers), CRXX +27.8% (discovers novel multi-target mechanism for the treatment of hematologic malignancies), AVAV +8.3% (mentioned positively in Barron's), HOTT +6.1% (Cramer makes positive comments on MadMoney), SIRI +4.2% (adds 171,441 net subscribers in 1Q), DRYS +1.7% (still checking for anything specific), SAP +1.5% (still checking), TEVA +0.7% (POZEN enters into settlement agreement with Teva regarding Paragraph IV patent litigation).<br /><br />Analyst comments: YGE +4.6% (initiated with a Buy at Auriga), TLAB +4.6% (upgraded to Buy from Neutral at UBS), VVUS +1.6% (initiated with a Buy at Needham), SOLF +1.5% (initiated with a Buy at Auriga), CREE +1.2% (upgraded to Buy at Morgan Joseph), ERIC +0.7% (upgraded to Buy from Neutral at Credit Suisse), MCD +0.7% (upgraded to Buy from Neutral at Janney Mntgmy Scott).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: HCSG -8.0%, ABCB -5.2% (light volume; also filed for $12 mln common stock offering in addition to $60 mln proposed maximum aggregate offering price already registered), GWW -3.4%, CJR -2.8% (light volume), ASML -1.6%.<br /><br />Other news: RPC -18.8% (announced the second closing of a 12% Convertible Promissory Note and Warrant financing), BMR -3.1% (announces public offering of 9,000,000 shares of common stock), NBG -3.7% (German threatens legal challenge over Greek aid - Reuters.com), CKSW -3.3% (files for a 15 mln ordinary share shelf offering), EXAS -1.9% (prices its 4.2 mln share common stock offering at $4.50/share).<br /><br />Analyst comments: MIPI -6.4% (downgraded to Market Perform from Outperform at Wells Fargo), MOS -2.1% (downgraded to Neutral from Buy at Goldman), POT -1.9% (downgraded to Neutral from Buy at Goldman), DNDN -1.3% (downgraded to Hold from Buy at Citigroup).